Nintedanib(BIBF1120) in Thyroid Cancer

NCT01788982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

NETWORK

Sponsor class

Conditions

Medullary Thyroid Cancer (MTC)
Differentiated Thyroid Cancer (DTC)

Interventions

DRUG: Nintedanib
DRUG: Placebo

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC